Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Peripheral Artery Disease Clinical Trials

100 recruiting trials for Peripheral Artery Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
6
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06275113

BRING-UP Prevention

The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral...

Sponsor: Heart Care FoundationEnrolling: 600020 locations
RECRUITINGNCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international...

Sponsor: Sanford HealthEnrolling: 200002 locations
RECRUITINGPhase 3NCT07223593

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

The purpose of this study is to evaluate the effect and safety of orforglipron once daily in participants with Fontaine II peripheral arterial disease (PAD). Participation in the...

Sponsor: Eli Lilly and CompanyEnrolling: 120520 locations
RECRUITINGNCT03195556

Augmentation of Limb Perfusion With Contrast Ultrasound

Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These...

Sponsor: Oregon Health and Science UniversityEnrolling: 301 location
RECRUITINGNCT04584632

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease...

To evaluate the safety and performance of the EVSS in patients with symptomatic peripheral vascular disease from stenosis or occlusion of the femoropopliteal artery

Sponsor: Efemoral Medical, Inc.Enrolling: 1008 locations
RECRUITINGPhase 4NCT05854641

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysian patients with...

Sponsor: Cell Biopeutics Resources Sdn BhdEnrolling: 101 location
RECRUITINGEarly Phase 1NCT06204237

Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers...

The goal of this Phase 0 clinical trial is to evaluate safety and biodistribution of \[89Zr\]Zr-DFO-APAC in patients with peripheral arterial occlusive disease / critical limb...

Sponsor: Aplagon OyEnrolling: 101 location
RECRUITINGNCT05192707

Transcutaneous Oxygen Pressure (TcPO2) Determination.

Upper limb arterial disease is a rare condition compared to lower limb arterial disease. In the lower limb, chronic limb ischemia (CLI) is characterized by an intractable pain or...

Sponsor: Hospices Civils de LyonEnrolling: 601 location
RECRUITINGNCT05749250

Ultrasound Cavitation Therapy for CLI

In this study, we will explore how ultrasound exposure of ultrasound contrast agents, which produces beneficial shear-mediated bioeffects, can be used to treat patients with...

Sponsor: University of VirginiaEnrolling: 301 location
RECRUITINGNCT06296576

Acceleration Time Assessment for Prediction of Critical Limb Ischemia

Critical Limb Ischaemia (CLI), the final stage of arterial disease, is a therapeutic emergency whose prognosis depends largely on the time taken to diagnose it. The growing...

Sponsor: Centre Hospitalier le MansEnrolling: 4313 locations
RECRUITINGNCT04511234

Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease

This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal...

Sponsor: Concept Medical Inc.Enrolling: 27920 locations
RECRUITINGNCT06299956

Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark

The goal of this project is to implement a protocol for a supervised exercise therapy intervention including smoking cessation in the municipalities in region Zealand in Denmark....

Sponsor: Slagelse HospitalEnrolling: 6001 location
RECRUITINGNCT06111599

Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment

Thermovision-controlled lumbar sympathetic blockade in chronic limb-threatening ischemia treatment

Sponsor: EPC Education s.r.o.Enrolling: 601 location
RECRUITINGPhase 3NCT04433572

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of ischemia-driven major...

Sponsor: Mercator MedSystems, Inc.Enrolling: 2502 locations
RECRUITINGNCT06687590

Serranator POINT FORCE Registry

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatment of peripheral...

Sponsor: Cagent Vascular LLCEnrolling: 50019 locations
RECRUITINGNCT01524276

Product Surveillance Registry

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is...

Sponsor: MedtronicEnrolling: 10000020 locations
RECRUITINGNCT06477289

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

This study will examine sleep disordered breathing and sleep quality in participants (ages 12-18) diagnosed with sickle cell disease of any genotype. We will utilize remote...

Sponsor: St. Jude Children's Research HospitalEnrolling: 651 location
RECRUITINGNCT06238050

NOrmoBaric Oxygen Therapy Use In Critical Limb ISchemia

Peripheral arteriopathy disease (PAD) affects 1 million people in France. In its most advanced stage: chronic permanent ischemia also called critical ischemia, the prognosis of...

Sponsor: University Hospital, AngersEnrolling: 2003 locations
RECRUITINGNCT04885985

ACOART BTK RENEW:A Post Market Clinical Study

The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Acotec Litos\&Tulip Drug-coated Balloon catheters...

Sponsor: Acotec Scientific Co., LtdEnrolling: 1071 location
RECRUITINGNCT02280733

A Real-World Registry of Chronic Wounds and Ulcers

WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data...

Sponsor: U.S. Wound RegistryEnrolling: 3000001 location
RECRUITINGNCT06410313

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of...

This is a prospective, open label, multicenter, single arm, first in human clinical study. Patients with infra-inguinal peripheral arterial disease appropriate for treatment with...

Sponsor: Medinol Ltd.Enrolling: 307 locations
RECRUITINGNCT06066268

miRNAs in Critical Limb Ischemia (miRNACLI)

For the present study, 40 patients affected by critical limb ischemia of different severity will be enrolled: patients affected by critical limb ischemia undergoing subgenual...

Sponsor: IRCCS Policlinico S. DonatoEnrolling: 801 location
RECRUITINGNCT07097857

Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency...

To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention

Sponsor: Singapore General HospitalEnrolling: 151 location
RECRUITINGNCT04889105

Exercise Therapy for PAD Using Mobile Health

Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans...

Sponsor: VA Office of Research and DevelopmentEnrolling: 751 location
RECRUITINGNCT06071429

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

The objective of this prospective, single-blinded, randomized controlled trial is to evaluate the safety and efficacy of the MAGNITUDE BRS System for the planned treatment of...

Sponsor: R3 Vascular Inc.Enrolling: 3003 locations
RECRUITINGNCT02748226

Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb...

1. Study design: multicenter retrospective and prospective observational study 2. Study Cohort : 1. Retrospective cohort: This cohort retrospectively enrolls patients with...

Sponsor: Yonsei UniversityEnrolling: 120001 location
RECRUITINGNCT06253312

Treatment of TASC C and D Aortoiliac Lesions

Background: The treatment of patients with complex aortoiliac disease (AID), classified as Trans-Atlantic Inter-Society consensus II (TASC) class C and D, presents a dilemma for...

Sponsor: Clinical Centre of SerbiaEnrolling: 9001 location
RECRUITINGEarly Phase 1NCT06174597

Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy

This clinical trial included 2 periods. During the first period, it was a single arm study to explore the safety of umbilical cord artery-derived stem cells (UCA-PSCs) in the...

Sponsor: Nanjing UniversityEnrolling: 401 location
RECRUITINGNCT06260488

Histological Segmentation of the Superficial Femoral Artery From Microscan to CT Using Artificial Intelligence

The femoropopliteal artery segment (FPAS) is one of the longest arteries in the human body, undergoing torsion, compression, flexion and extension due to lower limb movements....

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 201 location
RECRUITINGNCT07245082

Patients With Type 2 Diabetes

Diabetes mellitus

Sponsor: National Taiwan University HospitalEnrolling: 20001 location
RECRUITINGPhase 4NCT06873321

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Venous thromboembolism (VTE) has a high prevalence in patients with multiple comorbidities undergoing complex surgical procedures. Sometimes, extended prophylaxis for VTE with...

Sponsor: Science Valley Research InstituteEnrolling: 1001 location
RECRUITINGNCT06041880

Passive Calf Stretching Therapy in Peripheral Artery Disease

The goal of this clinical trial is to assess the effects of passive calf muscle stretching in patients diagnosed with peripheral artery disease (PAD). The main question it aims to...

Sponsor: Penn State UniversityEnrolling: 241 location
RECRUITINGNCT06832631

VITUS Post-Market Registry

To collect post marketing surveillance data on consecutive patients with peripheral arterial occlusive disease (PAOD) intended to be or treated by the VITUS peripheral drug-coated...

Sponsor: OrbusNeichEnrolling: 28413 locations
RECRUITINGNCT06124586

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

The planned study is a Randomized Controlled Monocentric Trial, which will provide evidence on whether early angiography in percutaneous transluminal angioplasty (PTA) readiness...

Sponsor: Heinrich-Heine University, DuesseldorfEnrolling: 2001 location
RECRUITINGNCT05612945

High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD

Supervised exercise training (SET) is considered among first-line therapies for patients with symptomatic lower extremity peripheral artery disease (PAD), combined with general...

Sponsor: Centre Hospitalier Universitaire VaudoisEnrolling: 601 location
RECRUITINGNCT05457738

Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application

The main characteristic of PAD is to limit physical activity by the appearance of claudication of the lower limbs which limits the walking distance, or the maximum distance...

Sponsor: CHU de ReimsEnrolling: 521 location
RECRUITINGNCT07350499

Aspiration Thrombectomy Using the Symphony or Prodigy System

The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures...

Sponsor: Imperative Care, Inc.Enrolling: 7501 location
RECRUITINGNCT06516315

Feasibility Study of an Angiographic Quantitative Flow Ratio-guided Endovascular Procedure in Patients With Lower Limbs...

The main objective of this study is to explore the feasibility of using the angiographic Quantitative Flow Ratio (QFR) as a tool to predict the success rate of endovascular...

Sponsor: Fondation Hôpital Saint-JosephEnrolling: 351 location
RECRUITINGNCT03186391

Exercise Testing in Peripheral Artery Disease Patients

The aim of this study was to evaluate exercise testing in case of patients suspected of Peripheral Artery Disease (PAD).

Sponsor: Rennes University HospitalEnrolling: 50001 location
RECRUITINGNCT04393389

Acotec DCB Post Market Clinical Follow-up

All-comers, prospective, multi-center, single-arm, non-interventional post market clinical follow-up (PMCF) Cohort 1 - Claudicants: Rutherford Clinical Category (RCC) 2-3 Cohort 2...

Sponsor: Acotec Scientific Co., LtdEnrolling: 30007 locations
RECRUITINGNCT05780359

Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

A multicenter, randomized, controlled, superiority clinical trial to evaluate the efficacy and safety of drug-eluting peripheral arterial stent system(G-stream) in the treatment...

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.Enrolling: 2801 location
RECRUITINGNCT06315023

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from...

Sponsor: EndologixEnrolling: 45010 locations
RECRUITINGNCT07068789

Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia

This interventional prospective study aims to assess the effectiveness of single vessel versus multiple vessel infrapopliteal angioplasty in patients with chronic threatening limb...

Sponsor: Sohag UniversityEnrolling: 401 location
RECRUITINGNCT06410521

Personalised Multicomponent Exercise Programme in Peripheral Arterial Disease

Peripheral arterial disease (PAD) is characterised as an atherosclerotic disease, most common in the lower limbs (aortoiliac, femoropopliteal, and infrapopliteal arterial...

Sponsor: University of Trás-os-Montes and Alto DouroEnrolling: 403 locations
RECRUITINGPhase 4NCT06909565

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing...

V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial...

Sponsor: Duke UniversityEnrolling: 600020 locations
RECRUITINGNCT01267591

Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children

Background: The reactive hyperemia-peripheral artery tonometry (RH-PAT) is a newly developed method for noninvasive endothelial function assessment. Objective: The goal of this...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 701 location
RECRUITINGNCT07226193

Detecting Peripheral Artery Disease With the Pulse

1\) The purpose of this study is to assess segmental pulse arrival time (PAT) as an alternative biomarker to detect lower-extremity peripheral artery disease (PAD), and to...

Sponsor: University of NebraskaEnrolling: 401 location
RECRUITINGNCT06631378

Transverse Versus Longitudinal Groin Incision in Vascular Surgery

The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery....

Sponsor: Kolding SygehusEnrolling: 2321 location
RECRUITINGNCT06182397

Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

This is a Pivotal, Prospective, randomized, two arm, placebo controlled, single-blind, multicenter trial that will be conducted at approximately 80 sites; approx. 50 sites with at...

Sponsor: Concept Medical Inc.Enrolling: 36820 locations
RECRUITINGNCT03203239

Red Light Treatment in Peripheral Artery Disease

Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (\<.9 or \>1.1) will undergo a single 5 min exposure of 670 nm light,...

Sponsor: University of Alabama at BirminghamEnrolling: 401 location

Showing 50 of 100 trials.Search all Peripheral Artery Disease trials

Frequently Asked Questions

There are currently 100 clinical trials for Peripheral Artery Disease, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Peripheral Artery Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 6 Phase 3 trials for Peripheral Artery Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.

The this entity record above pulls directly from the NIH ClinicalTrials.gov registry. What follows is the per-entity context — how this entity sits in the broader U.S. clinical trials and research registries distribution and which underlying factors drive the headline numbers.

Every number on this page links back to the NIH ClinicalTrials.gov registry; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within active and historical clinical trials. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.